PDL BIOPHARMA INC COM COM
PDL BIOPHARMA INC COM COM is a security (CUSIP 69329Y104) tracked across SEC portfolio filings. 8 institutional managers reported $29K on Form 13F as of 2026-06-30; 2 registered fund positions totaling $174K via N-PORT as of 2026-04-30.
Summary
- Issuer: PDL BIOPHARMA INC COM
- Class: COM
- CUSIP: 69329Y104
- Asset category: EC
- 13F holders: 8
- 13F value: $29K
- 13F period: 2026-06-30
- N-PORT fund positions: 2
- N-PORT value: $174K
- N-PORT report: 2026-04-30
Top institutional holders (Form 13F)
| Manager | Location | Value | Shares |
|---|
| DIVERSIFIED TRUST CO | MEMPHIS, TN | $28K | 11,554 |
| RHUMBLINE ADVISERS | BOSTON, MA | $2K | 612 |
| Financial Gravity Asset Management, Inc. | Lakeway, TX | — | 33 |
| Financial Gravity Companies, Inc. | Lakeway, TX | — | 13 |
| Motiv8 Investments LLC | Port St. Lucie, FL | — | 875 |
| Murphy & Mullick Capital Management Corp | SMITHTOWN, NY | — | 100 |
| Argent Trust Co | NASHVILLE, TN | — | 41,405 |
| Westside Investment Management, Inc. | SANTA MONICA, CA | — | 500 |
Top fund holders (N-PORT)
More